Home/Pipeline/iNstroke Catheters

iNstroke Catheters

Ischemic stroke

CommercialActive

Key Facts

Indication

Ischemic stroke

Phase

Commercial

Status

Active

Company

iVascularU

About iVascularU

iVascular is a privately-held, commercial-stage medical device company focused on the cardiovascular and neurovascular markets. Leveraging deep expertise in biopolymers, coatings, and drug delivery, the company has built a vertically integrated platform to develop and manufacture a portfolio of interventional devices, including the Angiolite drug-eluting stent and Luminor drug-coated balloon. With products approved in over 70 countries and a growing clinical evidence base, iVascular aims to be a European reference in vascular therapy through innovation and close collaboration with physicians.

View full company profile

Therapeutic Areas

Cardiovascular Neurovascular

Other Ischemic stroke Drugs

Drug	Company	Phase	Status
dl-3-n-Butylphthalide (NBP) Soft Capsules	cspc-pharmaceutical	Phase 3	Active (US trials with FDA orphan drug designation)
MultiStem	Athersys	Phase 3	Active (subject to funding)
IQool™ System	BrainCool	Clinical Evaluation	Evidence Generation
itMSCs + itNSCs	Stemedica Cell Technologies	Research	Active
BXT-25	BioXyTran	Preclinical	Active
Ischemic Stroke Program	CHS Pharma	Pre-clinical	Active
3K3A-APC	ZZ Biotech	Phase 2/3	Active
Ischemic Stroke Device(s)	Infinity Neuro	Pre-clinical	Active
THDG3	DeckTherapeutics	Pre-clinical	Active
Prometheus-based Gene Therapy	Remedium Bio	Pre-clinical	Active
Dual Thrombolytic Regimen (tPA + HisproUK)	Thrombolytic Science International	Phase 2	Active
Neural Stem Cell Therapy for Stroke	Neoneuron	Pre-clinical	Active